Day One Biopharmaceutical...

8.07
-0.12 (-1.47%)
At close: Mar 28, 2025, 3:59 PM
8.07
-0.06%
After-hours: Mar 28, 2025, 04:20 PM EDT

Day One Biopharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 124.97M 230.78M 85.26M 284.31M 43.73M 27.33M
Short-Term Investments 406.75M 135.56M 257.01M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 121K 214K 469K 169K 107K n/a
Receivables 13.88M n/a n/a n/a n/a n/a
Inventory 3.32M n/a n/a n/a n/a n/a
Other Current Assets 13.41M 8.93M 5.61M 5.06M 1.34M 7K
Total Current Assets 562.33M 375.27M 347.87M 289.37M 45.07M 27.34M
Property-Plant & Equipment 4.71M 560K 719K 284K 483K n/a
Goodwill & Intangibles 15.63M n/a n/a n/a n/a n/a
Total Long-Term Assets 20.46M 774K 1.19M 453K 590K n/a
Total Assets 582.79M 376.05M 349.06M 289.82M 45.66M 27.34M
Account Payables 3.26M 2.58M 260K 1.74M 202K 69K
Deferred Revenue 1.55M n/a n/a 6.61M 1.57M n/a
Short-Term Debt 10K 408K 810K 408K 198K n/a
Other Current Liabilities 68.63M 26.52M 15.54M 6.5M 1.6M 1.95M
Total Current Liabilities 73.45M 29.51M 16.61M 8.66M 2M 2.02M
Long-Term Debt 2.59M n/a 408K 16K 204K n/a
Other Long-Term Liabilities 3.99M n/a n/a n/a 91.96M 30.5M
Total Long-Term Liabilities 6.59M n/a 408K 16K 92.17M 30.5M
Total Liabilities 80.04M 29.51M 17.02M 8.67M 94.16M 32.52M
Total Debt 2.6M 408K 813K 220K 402K n/a
Common Stock 10K 9K 7K 6K 2M 2M
Retained Earnings -554.08M -458.58M -269.67M -127.49M -56.84M -12.78M
Comprehensive Income 84K 9K -71K 0.00 637.00 111.00
Shareholders Equity 502.75M 346.54M -269.67M -127.49M -54.2M -10.67M
Total Investments 406.75M 135.56M 257.01M n/a n/a n/a